Spanish experience with the ipilimumab Expanded Access Program.

被引：0

作者：

Berrocal, Alfonso

Lopez-Martin, Jose A.

Maria Arance, Ana

Soriano, V.

Espinosa, Enrique

Lopez Criado, M. Pilar

Munoz, Eva

Pablo Berros, Jose

Soria, A.

Marquez, I.

Sancho, P.

Gil, I.

机构：

[1] Univ Valencia, Consorcio Hosp Gen, Valencia, Spain

[2] Hosp 12 Octubre, E-28041 Madrid, Spain

[3] H Clin I Prov, Barcelona, Spain

[4] Inst Valenciano Oncol, Valencia, Spain

[5] Hosp Univ La Paz, Madrid, Spain

[6] MD Anderson Madrid, Madrid, Spain

[7] H Vall dHebron, Barcelona, Spain

[8] Hosp Univ Cent Asturias IUOPA, Oviedo, Spain

[9] Hosp Ramon & Cajal, E-28034 Madrid, Spain

[10] H Gregorio Maranon, Madrid, Spain

[11] Hosp Reina Sofia, Seville, Spain

[12] Hosp Reina Sofia, Navarra, Spain

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e19023

引用

页数：1

共 50 条

[31] Ipilimumab in the real world: the UK expanded access programme experience in previously treated advanced melanoma patients
Ahmad, Saif S.
Qian, Wendi
Ellis, Sarah
Mason, Elaine
Khattak, Muhammad A.
Gupta, Avinash
Shaw, Heather
Quinton, Amy
Kovarikova, Jarmila
Thillai, Kiruthikah
Rao, Ankit
Board, Ruth
Nobes, Jenny
Dalgleish, Angus
Grumett, Simon
Maraveyas, Anthony
Danson, Sarah
Talbot, Toby
Harries, Mark
Marples, Maria
Plummer, Ruth
Kumar, Satish
Nathan, Paul
Middleton, Mark R.
Larkin, James
Lorigan, Paul
Wheater, Matthew
Ottensmeier, Christian H.
Corrie, Pippa G.
MELANOMA RESEARCH, 2015, 25 (05) : 432 - 442
[32] IPILIMUMAB FOR ADVANCED MELANOMA IN AN EXPANDED ACCESS PROGRAMME (EAP): OCULAR, MUCOSAL AND ACRAL SUBTYPE UK EXPERIENCE
Shaw, H.
Larkin, J.
Corrie, P.
Ellis, S.
Nobes, J.
Marshall, E.
Kumar, S.
Danson, S.
Plummer, R.
Nathan, P.
ANNALS OF ONCOLOGY, 2012, 23 : 374 - 374
[33] Efavirenz Expanded Access Program
Stek, M
Patel, K
Shivaprakash, M
Menten, J
XIV INTERNATIONAL AIDS CONFERENCE: EPIDEMIOLOGY, 2002, : 205 - 207
[34] NIVEX TRIAL (GECP 1605): Nivolumab in the Real World: Spanish Expanded Access Program Experience in Pretreated Advanced NSCLC Patients
Rodriguez-Abreu, D.
Campillo, J.
Grau, F.
Carcereny, E.
Bernabe, R.
Garcia, Y.
Artal Cortes, A.
Gonzalez Cao, M.
Juan, O.
Garicano, F.
Gil-Bazo, I.
Blanco, R.
Guillot, M.
Provencio, M.
Majem, M.
JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S827 - S827
[35] Spanish MINISAT program. Objectives and operational results
Primo, MAG
ASTROPHYSICS AND SPACE SCIENCE, 2001, 276 (01) : 3 - 12
[36] Spanish MINISAT Program. Objectives and Operational Results
Miguel A. García Primo
Astrophysics and Space Science, 2001, 276 (1) : 3 - 12
[37] Spanish MINISAT program. Program objectives and operational results.
Primo, MAG
THIRD EURO-LATIN AMERICAN SPACE CONFERENCE, 1998, : 265 - 276
[38] Pembrolizumab Expanded Access Program (EAP) in Taiwan for patients with progressive advanced melanoma after prior ipilimumab treatment
Yang, C-K.
Liu, J-H.
Lin, C-C.
Liu, T-C.
Cheng, P-T.
Lin, C-Y.
Hu, H-T.
Cao, C-R.
Huang, W-T.
Chen, L-P.
Chang, W-C.
ANNALS OF ONCOLOGY, 2016, 27
[39] NUSINERSEN FOR SMA1: THE ITALIAN EXPANDED ACCESS PROGRAM (EAP) EXPERIENCE
Albamonte, E.
Pane, M.
Messina, S.
D'Amico
Bertini, E.
Bruno, C.
Vita, G.
Casiraghi, J.
Binetti, L.
Mercuri, E.
Sansone, V. A.
MUSCLE & NERVE, 2017, 56 : S2 - S3
[40] A single-institution experience with the pembrolizumab (PEM) Expanded Access Program (EAP)
Perdon, Karen Mae
Kim, Dae Won
Balmes, Gener C.
VanAnh Trinh
McIntyre, Susan E.
Diab, Adi
Amaria, Rodabe Navroze
Patel, Sapna Pradyuman
Hwu, Patrick
James, Marihella
Philip, Ann
Vardeleon, Anna
Cain, Suzanne
Hwu, Wen-Jen
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)

← 1 2 3 4 5 →